Jin-Sun Kim

Jin-Sun Kim is a notable inventor based in Yongin-si, South Korea. He has made significant contributions to the field of medical science, particularly in the treatment of hyperlipidemia. With a total of three patents to his name, his work focuses on innovative compositions that address critical health issues.

Latest Patents

One of Jin-Sun Kim's latest patents is a composition for treating hyperlipidemia that comprises an oxyntomodulin derivative. This invention relates to a composition aimed at preventing or treating hyperlipidemia, fatty liver disease, or arteriosclerosis. The oxyntomodulin derivative is noted for its high ability to activate GLP-1 and glucagon receptors compared to native oxyntomodulin. It effectively reduces blood total cholesterol, low-density cholesterol, and triglyceride levels that are elevated by a high-fat diet. Additionally, it increases high-density cholesterol levels and improves the high-density cholesterol/low-density cholesterol ratio. This oxyntomodulin derivative can be effectively utilized for the treatment of hyperlipidemia and related diseases.

Career Highlights

Jin-Sun Kim is currently associated with Hanmi Pharm Co., Ltd., where he continues to innovate in the pharmaceutical field. His work has garnered attention for its potential impact on public health, particularly in managing cholesterol levels and related conditions.

Collaborations

Some of his notable coworkers include Sung Youb Jung and Se Chang Kwon, who contribute to the collaborative efforts in research and development at Hanmi Pharm.

Conclusion

Jin-Sun Kim's innovative work in the treatment of hyperlipidemia showcases his commitment to advancing medical science. His contributions through patents reflect a significant step forward in addressing critical health challenges.

This text is generated by artificial intelligence and may not be accurate.